183 related articles for article (PubMed ID: 30832648)
1. Effects of resveratrol on Th17 cell-related immune responses under tacrolimus-based immunosuppression.
Doh KC; Kim BM; Kim KW; Chung BH; Yang CW
BMC Complement Altern Med; 2019 Mar; 19(1):54. PubMed ID: 30832648
[TBL] [Abstract][Full Text] [Related]
2. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM
Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982
[TBL] [Abstract][Full Text] [Related]
3. Suppressive Effect of 1α,25-Dihydroxyvitamin D3 on Th17-Immune Responses in Kidney Transplant Recipients With Tacrolimus-Based Immunosuppression.
Chung BH; Kim BM; Doh KC; Min JW; Cho ML; Kim KW; Yang CW
Transplantation; 2017 Jul; 101(7):1711-1719. PubMed ID: 28107277
[TBL] [Abstract][Full Text] [Related]
4. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients.
Kim KW; Chung BH; Kim BM; Cho ML; Yang CW
Immunology; 2015 Jan; 144(1):68-78. PubMed ID: 24974886
[TBL] [Abstract][Full Text] [Related]
5. Effects and mechanisms of tacrolimus on development of murine Th17 cells.
Zhang XJ; Kang YD; Xiao L; Li RD; Ding GS; Wang ZX; Fu ZR
Transplant Proc; 2010 Nov; 42(9):3779-83. PubMed ID: 21094856
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway.
Shibasaki S; Yamashita K; Goto R; Wakayama K; Tsunetoshi Y; Zaitsu M; Igarashi R; Haga S; Ozaki M; Umezawa K; Todo S
Transplantation; 2013 Feb; 95(4):542-50. PubMed ID: 23269193
[TBL] [Abstract][Full Text] [Related]
7. Age-Dependent Metabolic and Immunosuppressive Effects of Tacrolimus.
Krenzien F; Quante M; Heinbokel T; Seyda M; Minami K; Uehara H; Biefer HRC; Schuitenmaker JM; Gabardi S; Splith K; Schmelzle M; Petrides AK; Azuma H; Pratschke J; Li XC; ElKhal A; Tullius SG
Am J Transplant; 2017 May; 17(5):1242-1254. PubMed ID: 27754593
[TBL] [Abstract][Full Text] [Related]
8. Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance.
Lee SK; Park MJ; Jhun JY; Beak JA; Choi JW; Rye JY; Jang JW; Bae SH; Yoon SK; Choi HJ; You YK; Cho ML; Choi JY
Front Immunol; 2020; 11():581728. PubMed ID: 33488583
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of T Helper Cell Differentiation by Tacrolimus or Sirolimus Results in Reduced B-Cell Activation: Effects on T Follicular Helper Cells.
Kraaijeveld R; Li Y; Yan L; de Leur K; Dieterich M; Peeters AMA; Wang L; Shi Y; Baan CC
Transplant Proc; 2019 Dec; 51(10):3463-3473. PubMed ID: 31733794
[TBL] [Abstract][Full Text] [Related]
10. Impact of mycophenolic acid and tacrolimus on Th17-related immune response.
Abadja F; Atemkeng S; Alamartine E; Berthoux F; Mariat C
Transplantation; 2011 Aug; 92(4):396-403. PubMed ID: 21818055
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol and Metformin Recover Prefrontal Cortex AMPK Activation in Diet-Induced Obese Mice but Reduce BDNF and Synaptophysin Protein Content.
Yang AJT; Frendo-Cumbo S; MacPherson REK
J Alzheimers Dis; 2019; 71(3):945-956. PubMed ID: 31450493
[TBL] [Abstract][Full Text] [Related]
12. Roles of the tacrolimus-dependent transcription factor IRF4 in acute rejection after liver transplantation.
Tang T; Lu Q; Yang X; Liu X; Liao R; Zhang Y; Yang Z
Int Immunopharmacol; 2015 Sep; 28(1):257-63. PubMed ID: 26093273
[TBL] [Abstract][Full Text] [Related]
13. Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy.
Granata S; Santoro G; Signorini L; Malerba G; Patuzzo C; Gambaro G; Stallone G; Zaza G
Eur J Pharmacol; 2019 Sep; 859():172494. PubMed ID: 31238062
[TBL] [Abstract][Full Text] [Related]
14. Sirtuin 1 independent effects of resveratrol in INS-1E β-cells.
Erdogan CS; Mørup-Lendal M; Dalgaard LT; Vang O
Chem Biol Interact; 2017 Feb; 264():52-60. PubMed ID: 28108221
[TBL] [Abstract][Full Text] [Related]
15. Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545.
Deuse T; Hua X; Taylor V; Stubbendorff M; Baluom M; Chen Y; Park G; Velden J; Streichert T; Reichenspurner H; Robbins RC; Schrepfer S
Transplantation; 2012 Oct; 94(7):695-702. PubMed ID: 22971540
[TBL] [Abstract][Full Text] [Related]
16. Roles of BATF/JUN/IRF4 complex in tacrolimus mediated immunosuppression on Tfh cells in acute rejection after liver transplantation.
Tang T; Xu T; Liu X; Yang T; Zhang L; Yang Z
J Cell Physiol; 2021 Mar; 236(3):1776-1786. PubMed ID: 32749698
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of Th17 cells during the early post-transplant period in patients under calcineurin inhibitor based immunosuppression.
Chung BH; Kim KW; Kim BM; Piao SG; Lim SW; Choi BS; Park CW; Kim YS; Cho ML; Yang CW
PLoS One; 2012; 7(7):e42011. PubMed ID: 22848688
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic Drug-Drug Interaction on Human Peripheral Blood Mononuclear Cells Between Everolimus and Tacrolimus at the Therapeutic Concentration Range in Renal Transplantation.
Okihara M; Takeuchi H; Akiyama S; Yoshinaga R; Osato S; Akashi I; Kihara Y; Konno O; Iwamoto H; Oda T; Tanaka S; Unezaki S; Hirano T
Ann Transplant; 2021 Feb; 26():e928817. PubMed ID: 33633104
[TBL] [Abstract][Full Text] [Related]
19. mTOR Signaling pathway as a master regulator of memory CD8
Rostamzadeh D; Yousefi M; Haghshenas MR; Ahmadi M; Dolati S; Babaloo Z
J Cell Physiol; 2019 Aug; 234(8):12353-12368. PubMed ID: 30710341
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of inhibiting both mTOR and glutamine metabolism on the arthritis in SKG mice.
Ueda Y; Saegusa J; Okano T; Sendo S; Yamada H; Nishimura K; Morinobu A
Sci Rep; 2019 Apr; 9(1):6374. PubMed ID: 31011190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
